Anders Johnsson
31 – 40 of 49
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study.
(
- Contribution to journal › Article
-
Mark
Autocrine epidermal growth factor receptor ligand production and cetuximab response in head and neck squamous cell carcinoma cell lines.
(
- Contribution to journal › Article
- 2011
-
Mark
Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer.
(
- Contribution to journal › Article
- 2010
-
Mark
Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial
(
- Contribution to journal › Article
-
Mark
Multicentre phase I-II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable pancreatic and biliary tract cancer: The CORGI-U study
(
- Contribution to journal › Article
-
Mark
Reduced drug accumulation is more important in acquired resistance against oxaliplatin than against cisplatin in isogenic colon cancer cells.
(
- Contribution to journal › Article
- 2009
-
Mark
Multicentre phase II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable colorectal cancer: The CORGI-L study.
(
- Contribution to journal › Article
-
Mark
Epidermal growth factor receptor status and persistent activation of Akt and p44/42 MAPK pathways correlate with the effect of cetuximab in head and neck and colon cancer cell lines.
(
- Contribution to journal › Article
-
Mark
The effect on the small bowel of 5-FU and oxaliplatin in combination with radiation using a microcolony survival assay.
(
- Contribution to journal › Article
- 2008
-
Mark
Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma
(
- Contribution to journal › Article